Jin S. Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jin S. Cho has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Caraballo
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 7
22 shared publications - Alice E. Shin
Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, USA
22 shared publications - Andrew T. Chan
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
22 shared publications - Carmen Rios
Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, Boston, Massachusetts. 10
22 shared publications - Chi-Lee C. Ho
Department of Surgery, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York. 1
22 shared publications - Daniel C. Chung
Massachusetts General Hospital 1 Division of Gastroenterology Boston, Massachusetts
22 shared publications
Latest Publications
- Open Access
- 15 November 2026
- Published by The Company of Biologists in Development
- Vol. 153 (22)
Maternal Foxh1 loss reduces locus-specific H3K27me3 and disrupts lineage segregation
Polycomb Repressive Complex 2 (PRC2) establishes H3K27me3 marks to shape spatiotemporal gene expression during embryogenesis. How PRC2 is recruited to specific genomic loci remains debated, with a prevailing model favoring intrinsic chromatin affinity over recruitment by sequence-specific transcription factors. Here, we show that the maternally deposited pioneer transcription factor Foxh1 promotes PRC2 occupancy at specific genomic loci during zygotic genome activation in Xenopus. Foxh1 is a crucial mediator of Nodal signaling that pre-binds mesendodermal enhancers before signaling activation, facilitating enhanceosome assembly and coordinated mesendodermal gene expression in cooperation with other maternal transcription factors. Using maternal Foxh1-null embryos, we demonstrate that Foxh1 is also required for efficient Ezh2/PRC2 occupancy at a subset of Foxh1-bound loci. Loss of Foxh1 selectively reduces Ezh2 occupancy and associated H3K27me3 at these regions without substantially altering total Ezh2 levels. These findings support a dual-function model in which Foxh1 activates endodermal gene expression in endoderm, while promoting PRC2-associated repression of the same regulatory program in ectoderm. Thus, Foxh1 contributes to establishing spatially distinct epigenetic states that coordinate germ layer specification and lineage segregation during early embryogenesis.
- 15 November 2026
- Published by The Company of Biologists in Development
- Vol. 153 (22)
Open AccessMaternal Foxh1 loss reduces locus-specific H3K27me3 and disrupts lineage segregation
Polycomb Repressive Complex 2 (PRC2) establishes H3K27me3 marks to shape spatiotemporal gene expression during embryogenesis. How PRC2 is recruited to specific genomic loci remains debated, with a prevailing model favoring intrinsic chromatin affinity over recruitment by sequence-specific transcription factors. Here, we show that the maternally deposited pioneer transcription factor Foxh1 promotes PRC2 occupancy at specific genomic loci during zygotic genome activation in Xenopus. Foxh1 is a crucial mediator of Nodal signaling that pre-binds mesendodermal enhancers before signaling activation, facilitating enhanceosome assembly and coordinated mesendodermal gene expression in cooperation with other maternal transcription factors. Using maternal Foxh1-null embryos, we demonstrate that Foxh1 is also required for efficient Ezh2/PRC2 occupancy at a subset of Foxh1-bound loci. Loss of Foxh1 selectively reduces Ezh2 occupancy and associated H3K27me3 at these regions without substantially altering total Ezh2 levels. These findings support a dual-function model in which Foxh1 activates endodermal gene expression in endoderm, while promoting PRC2-associated repression of the same regulatory program in ectoderm. Thus, Foxh1 contributes to establishing spatially distinct epigenetic states that coordinate germ layer specification and lineage segregation during early embryogenesis.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 3 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 3 shows the progression of disease between 4and 8 week old TCON mice and the amount of ACTN4 and DPP4 in stomach tissue.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 3 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 3 shows the progression of disease between 4and 8 week old TCON mice and the amount of ACTN4 and DPP4 in stomach tissue.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 1 shows the effect using different lysis buffers has on protein identification in stool protein mass spectrometry.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 1 shows the effect using different lysis buffers has on protein identification in stool protein mass spectrometry.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 5 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 5 shows the effect of S1P pathway lipids on GC cell lines without the presence of C6-U-Cer inhibition.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 5 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 5 shows the effect of S1P pathway lipids on GC cell lines without the presence of C6-U-Cer inhibition.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 2 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Table 2 describes the biopsy information of patient derived organoid cell lines.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 2 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Table 2 describes the biopsy information of patient derived organoid cell lines.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Table 1 lists the age and sex of stool donors.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Table 1 lists the age and sex of stool donors.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 4 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 4 contains heat maps of stool proteins between various stool donor groups and emphasizes the differential abundance of protein profiles based on donor status.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 4 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 4 contains heat maps of stool proteins between various stool donor groups and emphasizes the differential abundance of protein profiles based on donor status.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 2 contains stomach immunofluorescence images for Figure 3B.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 2 contains stomach immunofluorescence images for Figure 3B.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 2 contains stomach immunofluorescence images for Figure 3B.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 2 contains stomach immunofluorescence images for Figure 3B.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 5 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 5 shows the effect of S1P pathway lipids on GC cell lines without the presence of C6-U-Cer inhibition.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 5 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
Supplemental Figure 5 shows the effect of S1P pathway lipids on GC cell lines without the presence of C6-U-Cer inhibition.